Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Ampio Pharmaceutical (AMPE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 222,504
  • Shares Outstanding, K 75,940
  • Annual Sales, $ 0 K
  • Annual Income, $ -19,160 K
  • 36-Month Beta 0.23
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.09
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 01/02/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.72 +70.35%
on 12/13/17
4.95 -40.81%
on 12/29/17
+1.25 (+74.40%)
since 12/12/17
3-Month
0.90 +225.56%
on 10/16/17
4.95 -40.81%
on 12/29/17
+1.87 (+176.42%)
since 10/12/17
52-Week
0.38 +671.05%
on 08/17/17
4.95 -40.81%
on 12/29/17
+1.98 (+208.42%)
since 01/12/17

Most Recent Stories

More News
Ampio Update of J.P. Morgan Meeting Events and Disease Modification Discussions

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today reported a heavy schedule of meetings throughout the four-day conference, predominately with significant pharmaceutical companies discussing the successful...

JPM : 113.42 (+0.67%)
AMPE : 2.93 (+0.34%)
Ampio Presentation at J.P. Morgan Healthcare Conference made available to all Shareholders

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) announces that the company will be updating potential collaborators and attending shareholders at the J.P. Morgan Healthcare Conference, the largest and most...

JPM : 113.42 (+0.67%)
AMPE : 2.93 (+0.34%)
Today's Research Reports on Stocks to Watch: Ampio Pharmaceuticals and Versartis

NEW YORK, NY / ACCESSWIRE / December 4, 2017 / It was an exciting day for biotech companies Ampio Pharmaceuticals and Versartis. Both stocks had big closes in the green. Ampio has engaged with LaVoieHealthScience...

VSAR : 2.15 (+3.61%)
AMPE : 2.93 (+0.34%)
Ampio Pharmaceuticals Announces Engagement of LaVoieHealthScience for Integrated Public and Investor Relations

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced the engagement of LaVoieHealthScience for their services in investor and public relations. LaVoieHealthScience will immediately begin designing...

AMPE : 2.93 (+0.34%)
Today's Research Reports on Stocks to Watch: Ampio Pharmaceuticals and Agenus Inc.

NEW YORK, NY / ACCESSWIRE / November 24, 2017 / Shares of Ampio blew up on Wednesday after encouraging data was published in a peer review journal about its Ampion serum that is being developed to treat...

AGEN : 3.87 (-0.26%)
MRK : 61.65 (+5.10%)
AMPE : 2.93 (+0.34%)
Ampio Announces Publication of Ampion(TM) Treatment of Severe Osteoarthritis of the Knee as a Feature Article in Orthopedics Peer-Reviewed Journal

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that a manuscript entitled: "LMWF-5A for the Treatment of Severe Osteoarthritis of the Knee: Integrated Analysis of Safety and Efficacy" has...

AMPE : 2.93 (+0.34%)
Ampio Pharmaceuticals, Inc. Announces Continued Listing Plan Accepted by NYSE American

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) ("Ampio" or the "Company") today announced the receipt of notification that the Company's plan to regain compliance with the NYSE American's continued...

AMPE : 2.93 (+0.34%)
Stock Performance Review on Biotech Industry -- Ampio Pharma, AmpliPhi Biosciences, Actinium Pharma, and BioPharmX

If you want a Stock Review on AMPE, APHB, ATNM, or BPMX then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. On Thursday, the NASDAQ Composite ended the...

BPMX : 0.13 (+8.33%)
APHB : 1.12 (+1.82%)
ATNM : 0.74 (+1.37%)
AMPE : 2.93 (+0.34%)
Ampio Pharmaceuticals, Inc. Announces Closing of Registered Direct Offering

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) ("Ampio") today announced that it has closed it's previously announced registered direct offering of 7,709,400 shares of common stock at a purchase price...

AMPE : 2.93 (+0.34%)
Ampio Pharmaceuticals, Inc. Announces Pricing of Registered Direct Offering

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that it has entered into a securities purchase agreement with investors providing for the registered sale of approximately $6.75 million of...

AMPE : 2.93 (+0.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Ampio Pharmaceuticals, Inc. develops proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation, CNS disease, and male sexual dysfunction. Principal products offered by the Company include Optina, an oral drug for the treatment of diabetic retinopathy and macular edema; and Vasaloc,...

See More

Key Turning Points

2nd Resistance Point 3.11
1st Resistance Point 3.02
Last Price 2.93
1st Support Level 2.85
2nd Support Level 2.77

See More

52-Week High 4.95
Fibonacci 61.8% 3.20
Last Price 2.93
Fibonacci 50% 2.66
Fibonacci 38.2% 2.13
52-Week Low 0.38

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.